Related Experiment Video
Updated: Jun 29, 2025

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
Targeting the chromatin binding of exportin-1 disrupts NFAT and T cell activation
Yi Fan Chen1,2, Maryam Ghazala1,2, Ryan M Friedrich1,2
1Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Abstract:
Exportin-1 (XPO1/CRM1) plays a central role in the nuclear-to-cytoplasmic transport of hundreds of proteins and contributes to other cellular processes, such as centrosome duplication. Small molecules targeting XPO1 induce cytotoxicity, and selinexor was approved by the Food and Drug Administration in 2019 as a cancer chemotherapy for relapsed multiple myeloma. Here, we describe a cell-type-dependent chromatin-binding function for XPO1 that is essential for the chromatin occupancy of NFAT transcription factors and thus the appropriate activation of T cells. Additionally, we establish a class of XPO1-targeting small molecules capable of disrupting the chromatin binding of XPO1 without perturbing nuclear export or inducing cytotoxicity. This work defines a broad transcription regulatory role for XPO1 that is essential for T cell activation as well as a new class of XPO1 modulators to enable therapeutic targeting of XPO1 beyond oncology including in T cell-driven autoimmune disorders.
Insights
Exportin-1 (XPO1) is crucial for T cell activation by binding to chromatin. New XPO1 modulators target this function, offering therapeutic potential beyond cancer, including for autoimmune disorders.
Area of Science:
- Cell Biology
- Molecular Biology
- Immunology
Background:
- Exportin-1 (XPO1/CRM1) mediates nuclear export and has roles in cell division.
- XPO1 inhibitors like selinexor are FDA-approved for cancer therapy.
- The precise role of XPO1 in T cell activation remained unclear.
Purpose of the Study:
- To investigate the role of XPO1 in T cell activation.
- To identify novel XPO1 modulators with a distinct mechanism of action.
Main Methods:
- Chromatin immunoprecipitation assays to assess XPO1 binding.
- T cell activation assays.
- Development and testing of novel small molecule inhibitors.
Main Results:
- XPO1 exhibits a cell-type-dependent chromatin-binding function essential for T cell activation.
- XPO1 chromatin binding is required for NFAT transcription factor occupancy.
- A new class of XPO1 modulators was identified that disrupts XPO1 chromatin binding without affecting nuclear export or causing cytotoxicity.
Conclusions:
- XPO1 plays a significant role in regulating T cell activation through chromatin binding.
- Novel XPO1 modulators offer a therapeutic strategy for T cell-driven autoimmune disorders, distinct from current oncology treatments.
More Related Videos
13:20Chromatin Immunoprecipitation ChIP to Assay Dynamic Histone Modification in Activated Gene Expression in Human Cells
Published on: July 29, 2010
10:57NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
Published on: January 12, 2020
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Co-activators and Co-repressors
Regulation of Nuclear Protein Sorting
Directionality of Nuclear Transport
Nuclear Protein Sorting
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...